RYTM FY 2019 Earnings — Rhythm Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

RYTMRhythm Pharmaceuticals, Inc.

$6B

FY 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$834,000

Operating Income

-$146M

Net Income

-$135M

EPS (Diluted)

$-3.70

Cash Flow

Operating Cash Flow

-$123M

Free Cash Flow

-$126M

Stock-Based Comp.

$12M

Balance Sheet

Total Assets

$309M

Total Liabilities

$28M

Stockholders' Equity

$281M

Cash & Equivalents

$62M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$834,000	-$442,000	-88.7%
Operating Income	-$146M	-$78M	-86.2%
Net Income	-$135M	-$74M	-81.8%